Background {#Sec1}
==========

Myopia is the most common type of refractive error and has a 15 to 49% prevalence worldwide \[[@CR1]\]. Refractive surgery is a way to correct refractive error and reduce dependence on eyeglasses or contact lenses.

Photorefractive keratectomy (PRK) was the first refractive surgery approved by the U.S. Food and Drug Administration (FDA) in 1996 \[[@CR2]\]. After epithelial removal, an excimer laser is used to remodel the cornea \[[@CR3]\]. The most frequent complication of PRK is postoperative pain \[[@CR4]\]. Soon after the development of PRK, laser-assisted in situ keratomileusis (LASIK), which was approved by FDA in 1998, \[[@CR5]\] replaced PRK and has been the predominant refractive surgery worldwide since the 1990s \[[@CR6]--[@CR8]\]. In the LASIK procedure, a lamellar corneal flap is created with a mechanical microkeratome, then the flap is lifted up and excimer laser is used to make an ablation on the underlying stromal bed. After the ablation is done, the corneal flap is repositioned on the surface of the cornea \[[@CR6]\]. After the femtosecond laser (FS) was introduced to the market in 2002, the corneal flap can be produced by FS laser instead of a microkeratome (FS-LASIK) \[[@CR9]\]. Laser-assisted sub-epithelial keratectomy (LASEK) is another common type of refractive surgery firstly published by Massimo Camelin in 1998 \[[@CR10]\]. Initially, an epithelial flap is detached using a diluted alcohol solution (usually 18 to 20%) on the cornea \[[@CR8]\]. The latter surgical procedure is the same as LASIK. In 2008, the efficacy and safety after femtosecond lenticule extraction (FLEX) were reported by Sekundo et al \[[@CR11]\]. In the FLEX procedure, a corneal flap and a lenticule from the corneal stroma under the flap are created by the femtosecond laser. The lenticule is removed with forceps \[[@CR11]\]. In 2011, a new procedure developed from FLEX named small incision lentiule extraction (SMILE) was reported by Shah et al., and it was approved by FDA in 2016 \[[@CR12], [@CR13]\]. In this technique, both the lenticule and side-cut incision are made using femtosecond laser. Different from FLEX, the lenticule is removed through a small incision rather than lifting the flap.

Corneal ectasia is one of the complications of refractive surgery \[[@CR14]\]. Although its prevalence has been reported at between only 0.04 and 0.6%, corneal ectasia is sight-threatening and may require corneal transplantation in some severe cases \[[@CR15], [@CR16]\]. Corneal biomechanical property changes can occur before the diagnosis of corneal ectasia, which is characterized by changes in corneal geometric features \[[@CR17]\]. To evaluate corneal biomechanics, the most widespread devices at the time of writing are ocular response analyzer (ORA) and Corvis ST system (CST) \[[@CR18], [@CR19]\]. Both of them are non-contact tonometry and share some common principle: an air pulse is produced and projects to the cornea, then a set of different variables are generated related to the cornea deformation \[[@CR20]\].

ORA uses a Scheimflug image to measure corneal deformation and produces two main biomechanical parameters. One is corneal hysteresis (CH), which is defined as the pressures (P1 and P2) difference and represents the ability to absorb the energy from the external force \[[@CR21]\]. This ability is primarily related to corneal viscoelastic properties \[[@CR22]\]. The other one is corneal resistance factor (CRF), which may indicate the overall corneal resistant ability \[[@CR23]\].

Corvis ST system applies air pulse on the cornea then observes and records the movements using a high-speed Scheimpflug video camera in real time \[[@CR7]\]. The first air puff (A1) causes the cornea to cave inward to the highest concavity (HC) and the second application (A2) is produced before it returns outwards to the natural shape. Accordingly, deformation amplitude (vertical deformation length of corneal apex), time, and length (horizontal deformation length of corneal apex) of A1, A2, and HC are calculated along with the velocity of A1 and A2. In some version of CST, deflection amplitude (deformation amplitude corrected by whole eye movement) and deflection length (deflection length of the cornea compared with the undeformed cornea) are provided at A1, A2 and HC \[[@CR24], [@CR25]\].

With a growing volume of refractive surgeries worldwide, the aim of this study was to compare SMILE with other corneal refractive surgeries for myopia studying the postoperative change in corneal biomechanical properties, which are often a precursor of clinically significant ectasia.

Methods {#Sec2}
=======

Inclusion and exclusion criteria {#Sec3}
--------------------------------

We selected the studies which performed corneal refractive surgery on adult myopia patients. The intervention was small incision lenticule extraction (SMILE). The comparator was other corneal refractive surgeries. We focused on the corneal biomechanics measured by ORA or Corvis ST as the outcome. Regarding study design, we included randomized controlled trials (RCTs), cohort, case-control or cross-sectional studies. Only studies in English were included.

Literature search and selection strategies {#Sec4}
------------------------------------------

The following databases were used: PubMed, Embase, and Web of Science. The search was limited to literature published from January 01, 2005 to April 17, 2019. Search term "((((((((ora) OR ocular response analyzer) OR covis st) OR cst) OR biomechanics) OR biomechanical)) AND ((lenticule\[Title/Abstract\]) OR lenticules\[Title/Abstract\])" was applied to all the above databases. Studies that may not be published in those databases were identified by searching International Clinical Trials Registry Platform with lenticule as the search term. All the identified publications were screened independently by two authors (Hui Guo and Seyed M Hosseini-Moghaddam). Disagreements were reviewed and solved by Hui Guo, who was also responsible for data extraction. The flow chart of study selection is shown in Fig. [1](#Fig1){ref-type="fig"} based on PRISMA guideline \[[@CR26]\].Fig. 1Flow Diagram of Literature Search And Study Selection

Data extraction {#Sec5}
---------------

Data extracted from the identified studies included the following information: name of the first author, year of publication, study location, surgery method, parameters of each surgery, sample size, length of follow-up, publication language, patient baseline characteristics \[age, spherical equivalent (SE), central corneal thickness (CCT), and intraocular pressure (IOP) before surgery\]. Regarding corneal biomechanical properties, we extracted the data including measure method, baseline value, the last follow-up value, and the change value from the baseline. If the study used ORA to measure corneal biomechanical properties, only the CH and CRF data were extracted. All the parameters achieved from CST were collected. Mean, standard deviation or standard error, and sample size were extracted for the summary measures.

Quality assessment {#Sec6}
------------------

We used Downs and Black checklist to assess literature quality, which includes reporting bias, external validity, information bias, selection bias, and power \[[@CR27]\]. There are 27 questions for the five sections of assessment and a 32 score maximum. We modified the last question as to whether power and sample size were calculated and scored it 1 for "yes" answer and 0 for "no" answer \[[@CR28]\]. Then our modified Downs and Black score ranges are given four quality levels: excellent (26--28); good (20--25); fair (15--19); and poor (≤14) \[[@CR29]\].

Statistical analysis {#Sec7}
--------------------

### Imputation of variance {#Sec8}

In the study of Li et al., \[[@CR30]\] the mean of postoperative values of CH and CRF were reported with the absence of standard deviation (SD), standard error (SE), correlated *p*-value, or 95% confidence interval (CI). We imputed the SD using the average of SD from the other four studies in the same subgroup.

### Within study calculation {#Sec9}
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with Y referring to the effect size, m to the number of outcomes, V to the variance of effect size, and r to the correlation between outcomes \[[@CR33]\].

The correlation between CH and CRF was calculated using the weighted mean of Pearson correlation results from three studies, and we obtained an r ≈ 0.71 \[[@CR24], [@CR34], [@CR35]\]. The correlation values among the outcomes from CST were obtained from the study of Bak-Nielsen et al \[[@CR24]\]. Among each study reporting CST data, only the parameters which were reported with the correlated r were used in the meta-analysis. The composites combined from the effect sizes of CH and CRF were named CH/CRF, and those of parameters achieved from CST were named CST outcome in the following text.

Since CH and CRF have a positive correlation, we combined the effect sizes of CH and CRF directly. By contrast, the parameters from CST decreased or increased after surgeries \[[@CR25], [@CR36]\] and included positive and negative correlations \[[@CR24]\]. We changed the sign of Hedges' g by multiplying − 1 if the outcomes were negatively correlated with A1 time \[[@CR37]\]. We also identified A1 time decreased after surgeries from previous studies \[[@CR25], [@CR36]\]. Examples of the combination of effect size and variance is shown in Table [1](#Tab1){ref-type="table"}. If the study provides both postoperative and change values (postoperative values subtract preoperative values), the change values were used in the meta-analyses.Table 1Example of how to combine effect size and variance of change score of CH and CRF within studiesStudyOutcome (mmHg)SMILELASIKEffect size (Hedges' g)Variance of Hedges' gCombined effect sizeCorrelation between CH and CRFCombined varianceMeanSDN (eye) at last follow-upMeanSDN (eye) at last follow-upAlper Agca \[[@CR38]\]CH−1.941.5230−1.981.5300.030.06−0.070.710.06CRF−2.961.6930−2.691.4430−0.170.07Di Wu \[[@CR39]\]CH−1.940.8237−2.341.08340.420.060.480.710.05CRF−3.590.9137−4.291.6340.540.06Wenjing Wu \[[@CR40]\]CH−1.861.1375−2.231.33750.30.030.40.710.02CRF−3.141.0675− 3.81.53750.50.03Bingjie Wang \[[@CR41]\]CH−2.551.4450− 2.531.3856−0.010.040.40.710.03CRF−2.241.2950−3.331.34560.820.04Abbreviation: *CH* corneal hysteresis, *CRF* corneal resistance factor, *LASIK* laser-assisted in situ keratomileusis, *SD* standard deviation, *SMILE* small incision lenticule extraction

Meta-analysis {#Sec10}
-------------

Both the CH/CRF and CST outcomes were pooled among studies using Hedges'g. Random-effects model was selected because heterogeneity was expected due to different population and treatment regimens. Heterogeneity among studies was evaluated by *χ* ^2^ test and quantified using the I^2^ statistics \[[@CR42], [@CR43]\]. All reported *p*-values are 2-sided. A *p*-value equal to or less than 0.05 was considered statistically significant. Comprehensive Meta-analysis Software version 3.3.070 was used for synthesizing the outcomes among studies.

Subgroup analysis {#Sec11}
-----------------

The meta-analysis for FS-LASIK as the comparator was divided with two subgroups based on whether follow-up time was longer than 12 months. LASEK and PRK was two separated subgroups in the comparison with SMILE. FS-LASIK and LASIK was analysed as two subgroups in the CST meta-analysis comparing SMILE and FS-LASIK/LASIK. Subgroup analyses for RCT or observational studies were conducted if applicable.

Results {#Sec12}
=======

Study identification and study characteristics {#Sec13}
----------------------------------------------

Using our search strategy, 1488 articles were identified with database searching and another 60 were identified in International Clinical Trials Registry Platform. After duplications were removed, 900 articles were reviewed for eligibility (Fig. [1](#Fig1){ref-type="fig"}). We included 22 studies in this review. Notably, we excluded one study comparing micro incision lenticule extraction and SMILE, because they are basically the same type of surgery using different incision length \[[@CR44]\].

Five studies were RCTs, 9 were prospective cohort studies, 6 were retrospective cohort studies, and 2 were cross-sectional studies. FS-LASIK/LASIK was conducted in 15 studies, FLEX was in 3 studies, LASEK was in four studies, and PRK was included in 1 study. The length of follow-up was between 3 to 6 months in 17 studies. Four studies followed patients equal to or longer than 12 months. One study observed patients until 1 month postoperatively. Details of characters of the studies are provided in Table [2](#Tab2){ref-type="table"}.Table 2Baseline characters of studiesFirst authorPublication yearStudy locationStudy designFollow-up (months)GroupN (eye) at baselineAge (year) Mean ± SDSE (D) Mean ± SDCCT (*μm*) Mean ± SDIOP (mmHg) Mean ± SDAnders H. Vestergaard \[[@CR45], [@CR46]\]2014/2019DenmarkRCT6SMILE3435.00 ± 7.00−7.65 ± 1.11552.00 ± 30.0016.10 ± 3.00FLEX3435.00 ± 7.00−7.59 ± 0.97553.00 ± 28.0015.80 ± 2.80Danyang Wang \[[@CR47]\]2014ChinaProspective cohort3SMILE (SE ≤−6.00D)12424.85 ± 4.34−4.45 ± 1.00553.57 ± 25.5015.75 ± 3.12FS-LASIK (SE ≤-6.00D)4925.47 ± 3.71−4.24 ± 1.40547.49 ± 35.0014.79 ± 2.87SMILE (SE \>−6.00D)6324.70 ± 4.68−7.38 ± 0.95556.00 ± 26.9116.97 ± 2.78FS-LASIK (SE \>−6.00D)3023.73 ± 3.94−7.60 ± 1.04539.43 ± 34.2316.17 ± 3.23Iben Bach Pedersen \[[@CR48]\]2014DenmarkCross-sectional16SMILE2940.90 ± 6.73−7.10 ± 1.56N/AN/A28FLEX3140.50 ± 9.47−7.43 ± 1.11N/AN/A37FS-LASIK3538.40 ± 44.55−7.40 ± 1.18N/AN/AKazutaka Kamiya \[[@CR49]\]2014JapanRCT3SMILE2431.80 ± 6.00−4.10 ± 1.70543.10 ± 32.4013.30 ± 3.20FLEX2431.80 ± 6.00−4.10 ± 1.70545.50 ± 31.8013.80 ± 3.30Di Wu \[[@CR39]\]2014ChinaProspective cohort6SMILE4025.75 ± 5.40−5.71 ± 1.19554.15 ± 24.77N/AFS-LASIK4024.25 ± 6.02−5.80 ± 1.14556.70 ± 30.60N/AAlper Agca \[[@CR38]\]2014TurkeyRCT6SMILE3026.63 ± 4.57−3.62 ± 1.79539.00 ± 28.00N/AFS-LASIK3026.63 ± 4.57−3.71 ± 1.83542.00 ± 37.00N/AYang Shen \[[@CR50]\]2014ChinaCross-sectional3SMILE1727.06 ± 6.77−6.48 ± 1.22557.65 ± 22.56N/ALASEK1822.89 ± 6.42−6.09 ± 1.87533.06 ± 29.38N/AFS-LASIK1729.53 ± 7.42−8.71 ± 2.02562.71 ± 20.96N/ARui Dou \[[@CR51]\]2015ChinaRetrospective cohort3SMILE3624.00 ± 8.07−3.87 ± 0.95538.00 ± 20.6015.64 ± 2.04LASEK3523.00 ± 3.36−3.51 ± 1.21532.00 ± 32.4015.99 ± 3.50Shervin Mir Mohi Sefat \[[@CR25]\]2015GermanyProspective cohort3SMILE4336.60 ± 7.70−3.81 ± 0.95553.10 ± 29.0015.80 ± 2.60FS-LASIK2636.20 ± 6.70−3.65 ± 1.12561.40 ± 30.1015.90 ± 1.90Wenjing Wu \[[@CR40]\]2015ChinaRetrospective cohort3SMILE7524.25 ± 5.38−5.49 ± 1.35547.69 ± 27.0615.80 ± 2.55FS-LASIK7524.28 ± 5.24−5.56 ± 1.76545.97 ± 27.7115.79 ± 2.78Hua Li \[[@CR30]\]2016ChinaRetrospective cohort6SMILE9725.00 ± 6.00−5.60 ± 1.43546.75 ± 26.0615.84 ± 2.12FS-LASIK9624.00 ± 6.00−5.95 ± 1.78542.86 ± 30.5415.58 ± 2.56Ihab Mohamed Osman \[[@CR36]\]2016EgyptRetrospective cohort1SMILE2526.28 ± 3.41−5.43 ± 1.17532.84 ± 16.3714.89 ± 3.15LASIK2526.88 ± 3.99−5.16 ± 1.42527.96 ± 16.2115.59 ± 3.23Bingjie Wang \[[@CR41]\]2016ChinaRetrospective cohort12SMILE5025.26 ± 6.64−7.60 ± 1.12542.96 ± 23.3414.68 ± 2.65FS-LASIK5624.75 ± 6.24−7.68 ± 1.19548.00 ± 23.9714.94 ± 2.36Lei Xia \[[@CR52]\]2016ChinaProspective cohort6SMILE6925.15 ± 4.42−5.04 ± 2.32545.50 ± 28.20N/AFS-LASIK5923.65 ± 3.87−5.13 ± 1.36538.80 ± 31.50N/AMinjie Chen \[[@CR53]\]2016ChinaProspective cohort3SMILE7526.30 ± 4.20−4.40 ± 1.00553.00 ± 26.50N/ALASEK7626.70 ± 5.20−3.70 ± 1.10542.40 ± 34.30N/AYusuf Yildirim \[[@CR54]\]2016TurkeyRetrospective cohort6SMILE4229.00 ± 5.90−3.50 ± 1.00528.10 ± 23.60N/APRK4227.60 ± 5.20−3.60 ± 0.60517.60 ± 24.60N/AJun Zhang \[[@CR55]\]2016ChinaProspective cohort3SMILE80N/A−5.12 ± 1.62550.80 ± 25.77N/AFS-LASIK80N/A−4.87 ± 1.80547.06 ± 29.53N/ARohit Shetty \[[@CR56]\]2017IndiaRCT6SMILE3124.00 ± 1.00−6.18 ± 0.41514.18 ± 4.5013.00 ± 0.45FS-LASIK3124.00 ± 1.00−7.22 ± 1.32517.00 ± 4.8913.50 ± 0.46Mohamed Nagy Elmohamady \[[@CR57]\]2018EgyptProspective cohort36SMILE3524.42 ± 5.91−8.05 ± 2.06579.32 ± 10.65N/ALASIK3023.84 ± 4.75−7.49 ± 2.05582.84 ± 12.25N/AFS-LASIK3823.84 ± 4.75−7.14 ± 1.97587.96 ± 12.06N/AManrong Yu \[[@CR58]\]2018ChinaProspective cohort36SMILE3223.40 ± 4.60−4.10 ± 0.80551.10 ± 23.1017.40 ± 4.60LASEK3225.70 ± 5.70−3.70 ± 1.00538.30 ± 34.6016.60 ± 2.50Esraa El-Mayah \[[@CR59]\]2018SpainProspective cohort3SMILE3029.53 ± 5.37−4.17 ± 1.86N/AN/AFS-LASIK3027.40 ± 4.95−3.97 ± 2.02N/AN/AAbbreviations: *CCT* central corneal thickness, *CH* corneal hysteresis, *CRF* corneal resistance factor, *FLEX* femtosecond lenticule extraction, *FS* femtosecond Laser, *IOP* intraocular pressure, *LASEK* laser-assisted subepithelial keratectomy, *LASIK* laser-Assisted in situ keratomileusis, *N/A* not available, *PRK* photorefractive keratectomy, *RCT* randomized controlled trial, *SD* standard deviation, *SE* spherical equivalent, *SMILE* small incision lenticule extraction

Surgical parameters {#Sec14}
-------------------

### SMILE {#Sec15}

Seventeen studies reported a cap thickness between 100 to 120 *μ* m \[[@CR25], [@CR30], [@CR39]--[@CR41], [@CR45], [@CR47]--[@CR53], [@CR55], [@CR56], [@CR58], [@CR59]\]. Only one study reported a 90 *μ* m thickness cap \[[@CR36]\]. The cap diameter was between 7.2 to 8 mm in 16 studies, \[[@CR25], [@CR30], [@CR36], [@CR38], [@CR41], [@CR45]--[@CR51], [@CR53], [@CR58]--[@CR60]\] and the diameter of the optical zone was between 6 to 7 mm in 19 studies \[[@CR25], [@CR30], [@CR36], [@CR38]--[@CR41], [@CR45], [@CR47]--[@CR49], [@CR51]--[@CR56], [@CR58], [@CR59]\]. Twelve studies were performed with an energy between 115 to 190 nJ \[[@CR30], [@CR36], [@CR38], [@CR40], [@CR41], [@CR45], [@CR47], [@CR49]--[@CR51], [@CR53], [@CR54], [@CR58]\].

### LASIK {#Sec16}

All the 14 studies \[[@CR25], [@CR30], [@CR38]--[@CR41], [@CR47], [@CR48], [@CR50], [@CR52], [@CR55]--[@CR57], [@CR59]\] performed FS-LASIK except for the study of Osman et al. and Elmohamady et al., \[[@CR36], [@CR57]\] in which microkeratome is used for the flap creation. The flap thickness was between 90 to 110 *μm* among the 14 studies which performed LASIK \[[@CR25], [@CR30], [@CR36], [@CR39]--[@CR41], [@CR47], [@CR48], [@CR50], [@CR52], [@CR55]--[@CR57], [@CR59]\]. Eleven studies reported a flap diameter of 7.3 to 9 mm, \[[@CR25], [@CR30], [@CR36], [@CR38]--[@CR40], [@CR47], [@CR48], [@CR50], [@CR52], [@CR56]\] and the optical zone was between 5.75 to 6.75 mm in another 11 studies \[[@CR25], [@CR36], [@CR38]--[@CR41], [@CR47], [@CR48], [@CR52], [@CR55], [@CR56]\]. The energy was described in 6 studies with 110 to 175 nJ \[[@CR30], [@CR38], [@CR41], [@CR47], [@CR50], [@CR52]\].

### FLEX {#Sec17}

Four studies included FLEX as a comparison treatment \[[@CR45], [@CR46], [@CR48], [@CR49]\]. In those four studies, the flap thickness was between 100 to 120 *μ* m with 7.5 to 7.9 mm in diameter and the diameter of lenticule was between 6 to 6.5 mm. Energy setting was reported in two studies with 125 to 170 nJ \[[@CR45], [@CR49]\].

### LASEK {#Sec18}

Two of the four studies which involved LASEK as the comparator reported an 8.5 mm flap diameter in 2 studies \[[@CR50], [@CR53]\] and optical zone was 6.25 to 6.75 mm in 1 study \[[@CR58]\] with and the energy for ablation of 150 nJ in all 3 studies \[[@CR50], [@CR53], [@CR58]\].

### PRK {#Sec19}

One study performed PRK as comparative surgery \[[@CR54]\]. The optical zone was 6.5 mm. Following the PRK surgery, 0.02% mitomycin C was applied on the eyes.

ORA and CST outcome {#Sec20}
-------------------

The data from ORA and CST measurement prepared for meta-analysis are shown in Table [3](#Tab3){ref-type="table"} and Table [4](#Tab4){ref-type="table"}.Table 3Data from ocular response analyzer (ORA) measurementFirst authorProcedureN (eye) at last follow-upPreoperative CH (mmHg)Postoperative CH (mmHg)CH change (mmHg)Preoperative CRF (mmHg)Postoperative CRF (mmHg)CRF change (mmHg)Mean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDAnders H. Vestergaard \[[@CR45], [@CR46]\]SMILE3411.00 ± 1.707.80 ± 1.30−3.30 ± 1.2010.90 ± 1.906.40 ± 1.40−4.60 ± 1.20FLEX3410.80 ± 1.708.00 ± 1.10−2.70 ± 1.3010.90 ± 1.806.40 ± 1.40−4.50 ± 1.20Danyang Wang \[[@CR47]\]SMILE(SE ≤ -6.00D)12410.56 ± 1.89N/AN/A10.48 ± 1.89N/AN/AFS-LASIK (SE ≤ -6.00D)4910.45 ± 1.33N/AN/A10.07 ± 1.40N/AN/ASMILE (SE \> −6.00D)6310.49 ± 1.51N/AN/A10.86 ± 1.59N/AN/AFS-LASIK (SE \> −6.00D)3010.15 ± 1.48N/AN/A10.15 ± 1.70N/AN/AIben Bach Pedersen \[[@CR48]\]SMILE29N/A8.56 ± 1.02N/AN/A7.12 ± 1.24N/AFLEX31N/A8.48 ± 1.00N/AN/A7.00 ± 1.22N/AFS-LASIK35N/A8.58 ± 0.89N/AN/A7.12 ± 1.06N/AKazutaka Kamiya \[[@CR49]\]SMILE2410.50 ± 1.308.50 ± 1.00N/A10.00 ± 1.707.10 ± 1.30N/AFLEX2410.40 ± 1.608.30 ± 1.10N/A9.80 ± 1.706.70 ± 1.40N/ADi Wu \[[@CR39]\]SMILE37^b^N/A8.59 ± 1.00−1.94 ± 0.82N/A7.78 ± 1.03−3.59 ± 0.91FS-LASIK34^b^N/A8.11 ± 0.66−2.34 ± 1.08N/A6.94 ± 0.66−4.29 ± 1.60Alper Agca \[[@CR38]\]SMILE3010.89 ± 1.798.95 ± 1.47−1.94 ± 1.5210.73 ± 1.717.77 ± 1.37−2.96 ± 1.69FS-LASIK3011.00 ± 1.539.02 ± 1.27−1.98 ± 1.5010.76 ± 1.458.07 ± 1.26−2.69 ± 1.44Rui Dou \[[@CR51]\]SMILE3610.00 ± 0.828.51 ± 0.84−1.48 ± 0.8010.10 ± 0.687.61 ± 0.83−2.49 ± 0.71LASEK359.99 ± 1.318.47 ± 1.29−1.52 ± 1.2310.21 ± 1.727.53 ± 1.42−2.68 ± 1.03Wenjing Wu \[[@CR40]\]SMILE7510.16 ± 1.308.30 ± 1.04−1.86 ± 1.1310.39 ± 1.527.25 ± 1.31−3.14 ± 1.06FS-LASIK7510.09 ± 1.387.86 ± 1.03−2.23 ± 1.3310.57 ± 1.646.77 ± 1.13−3.80 ± 1.53Hua Li \[[@CR30]\]SMILE44^b^10.16 ± N/A7.94 ± 1.07^a^N/A10.41 ± N/A6.83 ± 1.18^a^N/AFS-LASIK38^b^10.32 ± N/A7.84 ± 0.88^a^N/A10.74 ± N/A6.58 ± 1.01^a^N/AIhab Mohamed Osman \[[@CR36]\]SMILE2512.03 ± 1.769.99 ± 1.76N/A11.42 ± 1.689.43 ± 1.55N/ALASIK2511.59 ± 1.868.46 ± 1.76N/A11.00 ± 1.897.45 ± 2.39N/ABingjie Wang \[[@CR41]\]SMILE5010.52 ± 1.717.97 ± 2.05−2.55 ± 1.4410.07 ± 1.497.83 ± 1.64−2.24 ± 1.29FS-LASIK5610.85 ± 1.198.31 ± 1.62−2.53 ± 1.3810.62 ± 1.817.29 ± 1.76−3.33 ± 1.34Lei Xia \[[@CR52]\]SMILE6910.99 ± 1.658.58 ± 1.40N/A11.26 ± 1.947.05 ± 1.65N/AFS-LASIK5910.76 ± 1.677.97 ± 1.14N/A10.60 ± 1.996.31 ± 1.41N/AMinjie Chen \[[@CR53]\]SMILE67^b^10.40 ± 1.708.30 ± 1.20−2.20 ± 1.4011.00 ± 1.707.00 ± 1.20−4.10 ± 1.40LASEK66^b^10.00 ± 1.207.70 ± 1.20−2.20 ± 1.2010.30 ± 1.407.00 ± 1.50−3.30 ± 1.00Yusuf Yildirim \[[@CR54]\]SMILE4210.90 ± 1.708.40 ± 1.50−2.50 ± 1.1011.10 ± 1.507.90 ± 1.60−3.30 ± 1.10PRK4210.40 ± 1.308.50 ± 1.30−1.90 ± 1.2010.80 ± 1.107.40 ± 1.50−2.70 ± 1.10Jun Zhang \[[@CR55]\]SMILE8010.64 ± 1.097.91 ± 0.92N/A10.54 ± 1.537.07 ± 1.27N/AFS-LASIK8010.83 ± 1.608.00 ± 1.32N/A10.71 ± 1.746.82 ± 1.40N/AMohamed Nagy Elmohamady \[[@CR57]\]SMILE3510.58 ± 0.398.51 ± 0.51N/A10.21 ± 0.098.38 ± 0.59N/ALASIK3010.62 ± 0.537.58 ± 0.71N/A10.19 ± 0.127.17 ± 0.68N/AFS-LASIK3810.71 ± 0.477.60 ± 0.61N/A10.22 ± 0.107.25 ± 0.69N/AManrong Yu \[[@CR58]\]SMILE3210.50 ± 2.108.70 ± 1.40N/A11.10 ± 1.707.40 ± 1.10N/ALASEK3210.10 ± 1.308.80 ± 1.50N/A10.20 ± 1.607.20 ± 1.70N/AEsraa El-Mayah \[[@CR59]\]SMILE308.85 ± 1.807.37 ± 1.29−1.44 ± 1.658.53 ± 2.266.03 ± 1.63−2.49 ± 1.74FS-LASIK309.83 ± 1.437.83 ± 1.15−1.91 ± 0.779.76 ± 2.177.40 ± 1.35−2.33 ± 1.27Abbreviations: *CH* corneal hysteresis, *CRF* corneal resistance factor, *FLEX* femtosecond lenticule extraction, *FS* femtosecond Laser, *LASEK* laser-assisted subepithelial keratectomy, *LASIK* laser-Assisted in situ keratomileusis, *N/A* not available, *PRK* photorefractive keratectomy, *SMILE* small incision lenticule extraction. ^a^ the value of SD was imputed from the other four studies in the same subgroup. ^b^ The number of patients at the last follow-up visit differed from the number at baselineTable 4Postoperative outcomes of Corvis ST (CST)First authorIben Bach Pedersen \[[@CR48]\]Yang Shen \[[@CR50]\]Sherivin Mir Mohi Sefat \[[@CR25]\]Ihab Mohamed Osman \[[@CR36]\]SMILEFLEXFS-LASIKSMILELASEKFS-LASIKSMILEFS-LASIKSMILELASIKN (eye) at last follow-up29313517181743262525Mean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDMean ± SDA1 time (ms)6.75 ± 0.166.76 ± 0.176.82 ± 0.127.27 ± 0.207.35 ± 0.237.17 ± 0.176.79 ± 0.246.83 ± 0.188.23 ± 0.377.89 ± 0.44A1 deflection length (mm)1.91 ± 0.271.83 ± 0.281.90 ± 0.24N/AN/AN/A1.97 ± 0.242.06 ± 0.21N/AN/AA2 time (ms)21.80 ± 0.3821.70 ± 0.3921.70 ± 0.3523.08 ± 0.4422.80 ± 0.4422.92 ± 0.8221.88 ± 1.1122.05 ± 0.2722.03 ± 1.1120.28 ± 1.87HC deflection amplitude (mm)N/AN/AN/AN/AN/AN/A0.89 ± 0.070.92 ± 0.08N/AN/AHC deflection length (mm)5.93 ± 0.225.91 ± 0.225.88 ± 0.18N/AN/AN/A5.76 ± 0.225.82 ± 0.26N/AN/AHC deformation amplitude (mm)1.20 ± 0.051.18 ± 0.061.15 ± 0.121.17 ± 0.111.08 ± 0.111.19 ± 0.131.11 ± 0.091.12 ± 0.101.10 ± 0.081.26 ± 0.07HC time (ms)16.40 ± 0.0516.30 ± 0.5616.10 ± 0.4717.38 ± 0.8117.57 ± 0.7217.57 ± 0.8316.80 ± 0.3616.77 ± 0.3716.32 ± 1.1014.40 ± 1.27HC Radius (mm)6.25 ± 0.596.11 ± 0.616.06 ± 0.535.74 ± 0.916.30 ± 1.836.30 ± 1.416.60 ± 0.706.60 ± 0.676.91 ± 1.257.00 ± 1.06Abbreviations: *A* application, *FS* femtosecond laser, *HC* highest concavity, *LASEK* laser-assisted subepithelial keratectomy, *LASIK* laser-assisted in situ keratomileusis, *N/A* not available, *SD* standard deviation, *SMILE* small incision lenticule extraction. Specifically, we chose the subgroup data created in the study of Seafat et al. as this subgroup had a balance of spherical equivalent at baseline between the two intervention groups. Only one study provided the preoperative data of CST measurement. Therefore, we presented only the postoperative outcomes in this table

Meta-analyses for ORA outcomes {#Sec21}
------------------------------

In the studies with FS-LASIK as the comparator, 10 studies which provided postoperative or change value (postoperative value -- preoperative value) of CH and CRF were included in the meta-analysis (Fig. [2](#Fig2){ref-type="fig"}). In the subgroup with follow-up less than 12 months, the difference of Hedges' g between two groups was 0.24 (95% CI, − 0.06 to 0.53; *p* = 0.117; I^2^ = 25%). The difference in over 12-month follow-up subgroup was 0.66 (95% CI, 0.19 to 0.13; *p* = 0.006; I^2^ = 92%). The overall difference was 0.41 (95% CI, 0.00 to 0.81; *p* = 0.049; I^2^ = 78%). Since there is only one RCT in this meta-analysis, we conducted a subgroup analysis with observational studies only, the over-all effect size significantly favored SMILE.(Additional file [1](#MOESM1){ref-type="media"}) Compared to LASIK, SMILE also had a higher postoperative CH/CRF value with Hedges' g = 1.31 (95% CI, 0.54 to 2.08, *p* = 0.001; I^2^ = 77%) (Fig. [3](#Fig3){ref-type="fig"}).Fig. 2Forest Plot of Corneal Hysteresis/Corneal Resistance Factor (CH/CRF) for Studies Comparing Small Incision Lenticule Extraction (SMILE) with Femtosecond Laser-assisted in Situ Keratomileusis (FS-LASIK)Fig. 3Forest Plot of Corneal Hysteresis/Corneal Resistance Factor (CH/CRF) for Studies Comparing Small Incision Lenticule Extraction (SMILE) with Laser-assisted in Situ Keratomileusis (LASIK)

Three studies reported the CH and CRF outcomes comparing SMILE and FLEX. The effect size was almost comparable to SMILE with Hedges' g = − 0.01 (95% CI, − 0.31 to 0.30; *p* = 0.972; I^2^ = 20%) (Fig. [4](#Fig4){ref-type="fig"}). In the subgroup analysis which included only the RCT studies of Vetergaard et al. and Kamiya et al., the difference of Hedges' g was − 0.04 (95% CI, − 0.54 to 0.47; *p* = 0.882; I^2^ = 55%). In 2019, Vestergaard et al. used the data from the same cohort to obtain the new parameters of ORA \[[@CR46]\]. No differences between SMILE and FLEX were found in the majority of 37 outcomes except that w11 slightly favoured FLEX.Fig. 4Forest Plot of Corneal Hysteresis/Corneal Resistance Factor (CH/CRF) for Studies Comparing Small Incision Lenticule Extraction (SMILE) with Femtosecond Lenticule Extraction (FLEX)

One study performed PRK, and 3 performed LASEK with ORA as the postoperative measurement. Since both PRK and LASEK remove corneal epithelium before application laser on the corneal stromal bed, and the number of the studies was too small, we pooled the effect size of these two surgeries as to compare with SMILE. Although the difference was not significant, the result showed LASEK/PRK group had a less decrease of CH/CRF after surgery than SMILE with Hedges' g = − 0.26 (95% CI, − 0.67 to 0.16; *p* = 0.230; I^2^ = 54%). Both subgroup outcomes and overall outcomes are also provided in Fig. [5](#Fig5){ref-type="fig"}.Fig. 5Forest Plot of Corneal Hysteresis/Corneal Resistance Factor (CH/CRF) for Studies Comparing Small Incision Lenticule Extraction (SMILE) with Laser-assisted Subepithelial Keratectomy (LASEK) /Photorefractive Keratectomy (PRK) Group

Meta-analyses for CST outcomes {#Sec22}
------------------------------

Five studies reported corneal biomechanical outcomes with CST after FS-LASIK or LASIK. The studies and parameters that were used in the meta-analysis are shown in Table [4](#Tab4){ref-type="table"}. The difference between SMILE and FS-LASIK was not significant with Hedges' g = − 0.05 (95% CI, − 0.24 to 0.14; *p* = 0.612, I^2^ = 55%) (Fig. [6](#Fig6){ref-type="fig"}). Shetty et al. found both linear corneal stiffness and mean corneal stiffness obtained from CST were comparable between SMILE and FS-LASIK \[[@CR56]\]. Since the parameters used in this study differed from the other four studies, we did not include it in the meta-analysis.Fig. 6Forest Plot of Postoperative Corvis ST System (CST) Outcome for Studies Comparing Small Incision Lenticule Extraction (SMILE) with Femtosecond Laser-assisted in Situ Keratomileusis (FS-LASIK)/Laser-assisted in Situ Keratomileusis (LASIK) Group

The study of Pedersen et al. \[[@CR48]\] reported the CST outcome longer than 12 months after SMILE or FLEX. They found that eyes after both SMILE and FLEX had a significantly lower A1 deflection length compared with healthy eyes. The difference between SMILE and FLEX was not significant in HC deformation amplitude, HC radius, HC deflection length, HC time, A1 time, A1 deflection length, and A2 time.

Shen et al. \[[@CR50]\] included LASEK as the comparator. At the 3-month postoperative follow-up, the difference between SMILE and LASEK was not significant in A1 time, HC time, A2 time, A1 length, A2 length, peak distance, A1 velocity, A2 velocity, radius, or deformation amplitude.

Study quality assessment {#Sec23}
------------------------

In the 22 articles, the quality score ranged from 15 to 23. Eight were within good scale, and 14 were fair. Detail of quality assessment results is illustrated in Table [5](#Tab5){ref-type="table"}.Table 5Quality checklistNo. of questionQuestionAnswerScoreAnders H. Vestergaard \[[@CR45], [@CR46]\]Danyang Wang \[[@CR47]\]Iben Bach Pedersen \[[@CR48]\]Kazutaka Kamiya \[[@CR49]\]Di Wu \[[@CR39]\]Alper Agca \[[@CR38]\]Yang Shen \[[@CR50]\]Rui Dou \[[@CR51]\]Shrvin Mir Mohi Sefat \[[@CR25]\]Wenjing Wu \[[@CR40]\]Hua Li \[[@CR30]\]Ihab Mohamed Osman \[[@CR36]\]Bingjie Wang \[[@CR41]\]Lei Xia \[[@CR52]\]Minjie Chen \[[@CR53]\]Yusuf Yidirim \[[@CR54]\]Jun Zhang \[[@CR55]\]Rohit Shetty \[[@CR56]\]Mohamed Nagy Elmohamady \[[@CR57]\]Manrong Yu \[[@CR61]\]EsraaEl-Mayah \[[@CR59]\]1Is the hypothesis /aim/objective of the study clearly described?YES1XXXXXXXXXXXXXXXXXXXXXNO02Are the main outcomes to be measured clearly described in the Introduction or Methods section?YES1XXXXXXXXXXXXXXXXXXXXXNO03Are the characteristics of the patients included in the study clearly described?YES1XXXXXXXXXXXXXXXXXXXXNO0X4Are the interventions of interest clearly described?YES1XXXXXXXXXXXXXXXXXXXXXNO05Are the distributions of principal confounders in each group of subjects to be compared clearly described?YES2XXXXXXXXXXXXXXXXXPARTIALLY1XXXXNO06Are the main findings of the study clearly described?YES1XXXXXXXXXXXXXXXXXXXXNO0X7Does the study provide estimates of the random variability in the data for the main outcomes?YES1XXXXXXXXXXXXXXXXXXXXNO0X8Have all important adverse events that may be a consequence of the intervention been reported?YES1XXXXXXXXXXXXXNO0XXXXXXXX9Have the characteristics of patients lost to follow-up been described?YES1XXXXXXXXXXXXXXXNO0XXXXXX10Have actual probability values been reported for the main outcomes except where the probability value is less than 0.001?YES1XXXXXXXXXXXXXXXXXXNO0XXX11Were the subjects asked to participate in the study representative of the entire population from which they were recruited?YES1XXXXXXNO0UNABLE TO DETERMINE0XXXXXXXXXXXXXXX12Were those subjects who were prepared to participate representative of the entire population from which they were recruited?YES1XNO0XXXUNABLE TO DETERMINE0XXXXXXXXXXXXXXXXX13Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive?YES1XXXXXXXXXXXXXXNO0XUNABLE TO DETERMINE0XXXXXX14Was an attempt made to blind study subjects to the intervention they have received?YES1NO0XXXXXXXUNABLE TO DETERMINE0XXXXXXXXXXXXXX15Was an attempt made to blind those measuring the main outcomes of the intervention?YES1NO0XXXXUNABLE TO DETERMINE0XXXXXXXXXXXXXXXXX16If any of the results of the study were based on "data dredging", was this made clear?YES1XXXXXXXXXXXNO0XXXXXXXXXUNABLE TO DETERMINE0X17In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case-control studies, is the time period between the intervention and outcome the same for cases and controls?YES1XXXXXXXXXXXXXXXNO0UNABLE TO DETERMINE0XXXXXX18Were the statistical tests used to asses the main outcomes appropriate?YES1XXXXXXXXXXXXXXXXXNO0XXXXUNABLE TO DETERMINE019Was compliance with the inerventions reliable?YES1XXXXXXXXXXXXXXXXXXXXXNO0UNABLE TO DETERMINE020Were the main outcome measures used accurate (valid and reliable)?YES1XXXXXXXXXXXXXXXXXXXXXNO0UNABLE TO DETERMINE021Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited from the same population?YES1XXXXXXXXXXXXXXXXXXXNO0UNABLE TO DETERMINE0XX22Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited over the same period of time?YES1XXXXXXXXXXXXXXXXXXXNO0UNABLE TO DETERMINE0XX23Were study subjects randomised to intervention groups?YES1XXXNO0XXXXXXXUNABLE TO DETERMINE0XXXXXXXXXXX24Was the randomised intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable?YES1XNO0XXXXXXXXXXXUNABLE TO DETERMINE0XXXXXXXXX25Was there adequate adjustment for confounding in the analyses from which the main findings were drawn?YES1XXXXXXXXXXNO0XXXXXXXXXXUNABLE TO DETERMINE0X26Were losses of patients to follow-up taken into account?YES1XXXXXXXXXXXXNO0XXXUNABLE TO DETERMINE0XXXXXX27Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%YES1XXXXXNO0XXXXXXXXXXXXXXXTotal scores28201722171822191815201520191715161823162117excellent (26--28); good (20--25); fair (15--19); poor (≤14)GoodFairGoodFairFairGoodFairFairFairGoodFairGoodFairFairFairFairFairGoodFairGoodFair

Sensitivity analysis {#Sec24}
--------------------

We removed two studies from the meta-analysis for comparing SMILE and FS-LASIK. One is the study of Li et al. because the SD in this study was imputed \[[@CR30]\]. Another one is the study of Elmohamady et al. since the effect size of the study was much higher than the rest of the studies. In this meta-analysis, the outcome was significantly favoured SMILE with Hedges' g = 0.25 (95% CI, 0.007 to 0.08; *p* = 0.003, I^2^ = 28%) (Additional file [2](#MOESM2){ref-type="media"}).

Discussion {#Sec25}
==========

To our best knowledge, this is the first systematic review and meta-analysis comparing SMILE with all the other corneal refractive surgeries in corneal biomechanical properties. We included 22 articles in this review with 19 articles in the meta-analyses.

According to the CH and CRF value measured with ORA, corneal biomechanical strength was preserved significantly better after SMILE than either FS-LASIK or LASIK. After conducting a sensitivity analysis, the result was robust after removing the possible biased data. Similarly, Yan et al. performed a meta-analysis with five studies, which are included in our meta-analysis, and reported a significant larger CH and CRF value after SMILE than FS-LASIK \[[@CR62]\]. Furthermore, we found the difference was greater after postoperative 12 months. This might indicate wound healing is better after SMLE. By contrast, we did not find a significant difference between SMILE and FS-LASIK in the postoperative outcomes from CST. The conclusion based on CST agreed with the majority of the studies in this review \[[@CR25], [@CR48], [@CR50], [@CR56]\]. The study of Osman et al. found A1 time, A2 time, A2 length, HC time HC radius, HC peak distance, and deformation amplitude were significantly different between SMILE and LASIK group \[[@CR36]\]. It is the only divergent study which used a microkeratome to create a corneal flap rather than femtosecond laser used in the other three studies. It might be the reason for the discrepancy of the conclusion.

In our meta-analysis, the corneal biomechanics was not statistically different between SMILE and FLEX. This conclusion agreed with the meta-analysis of Ma et al \[[@CR63]\]. They used postoperative CH and CRF value in different subgroup analysis and pooled the results of the two subgroups. The difference between SMILE and FLEX was 0.08 mmHg (95% CI, − 0.17 to 0.33; *p* = 0.54). We found only one study comparing SMILE with FLEX in CST outcomes \[[@CR48]\]. The study did not find a significant difference in the postoperative values between the two surgeries.

The CH/CRF value was greater after PRK/LASEK compared with SMILE although the difference did not reach a significance. In the study of Yildirim et al., the amount of stromal tissue removed by SMILE was significantly greater than PRK \[[@CR54]\]. This may bias the result because of the greater lenticule thickness or ablation depth the more decrease of CH and CRF value after refractive surgeries \[[@CR51], [@CR54]\]. By contrast, Dou et al. did not find a significant difference between SMILE and LASEK in CH or CRF decrease \[[@CR51]\]. However, the decrease of CH or CRF per unit of removed tissue was significantly smaller after SMILE than LASEK. We identified only one study comparing SMILE with LASEK in CST. No statistically significant difference between the two treatments was found in this study \[[@CR50]\].

Explanations for the outcome {#Sec26}
----------------------------

It has been hypothesized by many authors that SMILE is superior to LASIK in preserving the biomechanical properties of corneas because of its flapless procedure \[[@CR39], [@CR47], [@CR48], [@CR52]\]. The difference between flap versus flapless procedure was also found in the study of Kamiya et al. finding that CH and CRF had a significantly greater decrease after LASIK than after PRK \[[@CR64]\].

A vitro experimental study found that the vertical side cuts of corneal lamellae contributed more of the loss of structural integrity than horizontal delamination incisions \[[@CR65]\]. This can explain why flap procedure is more likely to lower corneal biomechanics.

However, we found that although SMILE was better than LASIK in the outcome from ORA, SMILE was comparable to FLEX, which also included a flap-creation procedure. This may be explained by: first, the number of studies was too small to identify the difference between SMILE and FLEX; second, CH and CRF were correlated to the flap thickness.

It is possible that the thickness of the flap, which was created in the anterior lamellae was responsible for the significant decrease of CH and CRF value. In the included studies, the flap thickness in the LASIK group was between 90 to 110 *μm* and it was between 100 to 120 *μ* m in FLEX group. A laboratory study found that the anterior part of the corneal stroma (100 to 120 *μ* m) was rigid due to the tightly interwoven anterior lamellae \[[@CR66]\]. This physiological property of cornea was approved in the vivo study from Wang et al \[[@CR47]\]. They found that the significantly lower CH and CRF value after LASIK than SMILE was only identified in high myopia subgroup while not in low myopia subgroup. They also pointed out that the corneal flap was thinner in high myopia patients than low myopia patients treated with LASIK. It indicated that the more anterior part of stromal lamellae was affected, the more biomechanical strength was weakened.

Limitations {#Sec27}
-----------

There were some limitations in our study. (1) The number of studies was small, especially of the studies performing FLEX, PRK, or LASEK as comparators. (2) Only five studies in this review were RCT design. Confounders were possible to be introduced in other types of studies and bias the outcomes. (3) All the meta-analysis included no more than 10 studies, which made the test of publication bias problematic \[[@CR67]\]. (4) The way in which we used to synthesize effect size of CH and CRF in the meta-analysis made it impossible to compare the two parameters in the efficacy of detecting the corneal biomechanical change. However, ignoring the correlation between multiple outcomes and treating the outcomes as a unit separately in the meta-analysis will overestimate the precision of the summary effects \[[@CR33]\]. (5) High heterogeneity across studies made the mean estimate less certain in this review. It may be caused by the diverse characteristics of patients and different study design across studies. Meta-regression analysis may be the best way to address this problem. However, this method might not be applicable to such a small number of study \[[@CR37]\]. Alternatively, we did subgroup analyses to reduce this possible bias.

Perspective {#Sec28}
-----------

To evaluate the impact of SMILE on corneal biomechanical properties compared with other corneal refractive surgeries, studies could be done based on several considerations. Initially, RCT would be the best study design for this scientific question, and blinding for measurement is necessary. Second, it is better to do subgroup analysis by dividing patients into low myopia and high myopia groups. Furthermore, if available, both ORA and CST measurements can be performed to evaluate the corneal biomechanical change and compare the outcomes. Longer follow-up time (more than 6 months) is necessary for better evaluation of the efficacy and safety of refractive surgery. Adverse events should be reported when publishing the study.

Conclusions {#Sec29}
===========

Our results from ORA indicated that SMILE was superior to FS-LASIK/LASIK in preserving corneal biomechanical strength after surgery. SMILE versus FLEX, PRK, or LASEK regarding corneal biomechanical properties were studied in only a few trials. The biomechanical outcomes between SMILE and FLEX were comparable. Although no significant difference was found, PRK/LASEK group showed better outcomes than SMILE. CST was not sensitive in detecting the difference of postoperative corneal biomechanical properties between surgeries in our meta-analysis.

Additional files
================

 {#Sec30}

Additional file 1:Forest Plot of Corneal Hysteresis/Corneal Resistance Factor (CH/CRF) for Observational Studies Comparing Small Incision Lenticule Extraction (SMILE) with Femtosecond Laser-assisted in Situ Keratomileusis (FS-LASIK). (PDF 54 kb) Additional file 2:Forest Plot of Corneal Hysteresis/Corneal Resistance Factor (CH/CRF) for Studies Comparing Small Incision Lenticule Extraction (SMILE) with Femtosecond Laserassisted in Situ Keratomileusis (FS-LASIK) from a Sensitivity Analysis. (PDF 53 kb)

CCT

:   Central corneal thickness

CH

:   Corneal hysteresis

CRF

:   Corneal resistance factor

CST

:   Corvis ST system

FLEX

:   Femtosecond lenticule extraction

FS

:   femtosecond laser

IOP**'**

:   Intraocular pressure

LASEK

:   Laser-assisted sub-epithelial keratectomy

LASIK

:   Laser-assisted in situ keratomileusis

ORA

:   Ocular response analyzer

PRK

:   Photorefractive keratectomy

RCTs

:   Randomized controlled trials

SE

:   Spherical equivalent

SMILE

:   Small incision lenticule extraction

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

I would thank for the tutorial of systematic review and meta-analysis from Dr. Monali Madhukar Malvankar (PhD) (Departments of Ophthalmology, Physiology and Health Sciences, The University of Western Ontario, London, Canada) and Rohin Jayaram Krishnan (Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Canada).

HG was responsible for study design, literature search and screening as well as data analyses and interpretation. SMH was responsible for literature screening and data analyses. WH was a major contributor of study design and writing. All authors read and approved the final manuscript.

The authors have no funding to disclose.

Data used in the analyses can be found in the published article, which were listed in the references of this manuscript.

Not applicable.

Not applicable.

The authors declare that they have no competing interests.
